AdaptHealth Corp.

AHCO

US00653Q1022

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
10.06 ^USD	+2.13%		+2.86%	+38.00%

Apr. 17	AdaptHealth Names Suzanne Foster as CEO	MT
Apr. 17	AdaptHealth Names Suzanne Foster CEO	DJ

AdaptHealth Corp. Announces Goodwill Impairment Charges for the Quarter Ended December 31, 2023

February 27, 2024 at 07:00 am EST

AdaptHealth Corp. announced Goodwill impairment charges for the quarter ended December 31, 2023. For the quarter, the company reported Goodwill impairment of $318,921,000.

Latest news about AdaptHealth Corp.

AdaptHealth Names Suzanne Foster as CEO	Apr. 17	MT
AdaptHealth Names Suzanne Foster CEO	Apr. 17	DJ
AdaptHealth Corp. Announces Chief Executive Officer Changes	Apr. 17	CI
AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024	Apr. 17	CI
Health Care Down as Viking Move Rattles Novo Shares -- Health Care Roundup	Feb. 27	DJ
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb	Feb. 27	MT
Transcript : AdaptHealth Corp., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 27	CI
AdaptHealth Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M	Feb. 27	MT
AdaptHealth Corp. Announces Goodwill Impairment Charges for the Quarter Ended December 31, 2023	Feb. 27	CI
North American Morning Briefing : Stock Futures Pause as Investors Eye Inflation Data	Feb. 27	DJ
One Equity Partners appoints Belinfanti as new president	Jan. 30	RE
Transcript : AdaptHealth Corp. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM	Jan. 10
Transcript : AdaptHealth Corp. Presents at Bank of America Virtual Home Care Conference 2023, Dec-05-2023 01:20 PM	Dec. 05
North American Morning Briefing : Traders Await -2-	Nov. 09	DJ
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says	Nov. 08	MT
Transcript : AdaptHealth Corp., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M	Nov. 07	MT
Tranche Update on AdaptHealth Corp.'s Equity Buyback Plan announced on May 10, 2022.	Nov. 07	CI
AdaptHealth Corp. Reports Unaudited Consolidated Impairment Charges Results for the Third Quarter Ended September 30, 2023	Nov. 07	CI
AdaptHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Adapthealth Corp. Updates Revenue Guidance for the Year 2023	Nov. 07	CI
AdaptHealth Chief Executive Officer Steps Down	23-09-20	MT
AdaptHealth says terminated appointment contract for incoming CEO	23-09-20	RE

Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for AdaptHealth Corp.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

10.06 USD

Average target price

11.85 USD

Spread / Average Target

+17.79%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ADAPTHEALTH CORP.	+38.00%	1.35B
ABBOTT LABORATORIES	-3.43%	184B
MEDTRONIC PLC	-1.81%	107B
BECTON, DICKINSON AND COMPANY	-4.15%	67.52B
DEXCOM, INC.	+1.43%	50.06B
CENCORA, INC.	+11.60%	45.67B
HOYA CORPORATION	+3.40%	41B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.03%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+3.21%	26.47B
TERUMO CORPORATION	+15.23%	25.05B

Other Medical Equipment, Supplies & Distribution